Clinical Trials on Graft vs Host Disease in United Kingdom
Total 2350 results
-
Dana-Farber Cancer InstituteBayer; Genzyme, a Sanofi CompanyCompleted
-
Washington University School of MedicineCompletedGraft Vs Host Disease | Graft-versus-host-diseaseUnited States
-
Christopher DvorakRecruitingGraft Vs Host Disease | Graft-versus-host-diseaseUnited States
-
Novartis PharmaceuticalsCompletedCorticosteroid Refractory Acute Graft vs Host DiseaseGermany, Japan, Saudi Arabia, Turkey, United Kingdom, Spain, Canada, Italy, Australia, Austria, France, Korea, Republic of, Hong Kong, Israel, Netherlands, Russian Federation, Denmark, Greece, Taiwan, Norway, Czechia, Bulgaria
-
National Cancer Institute (NCI)TerminatedGraft vs Host Disease | Graft-Versus-Host Disease | Chronic Graft vs. Host DiseaseUnited States
-
Cynata Therapeutics LimitedCompletedGraft vs Host DiseaseAustralia, United Kingdom
-
Dana-Farber Cancer InstituteWyeth is now a wholly owned subsidiary of Pfizer; PDL BioPharma, Inc.Terminated
-
Children's Hospital Medical Center, CincinnatiCompletedGraft Vs Host DiseaseUnited States
-
AbgenixSangstat Medical CorporationCompletedGraft Vs Host DiseaseUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteGateway for Cancer ResearchCompletedGraft vs. Host DiseaseUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedGraft Versus Host DiseaseUnited States, United Kingdom, Austria, Germany
-
Enteron PharmaceuticalsCompletedGraft Vs Host Disease | Gastrointestinal Graft-Versus-Host DiseaseUnited States
-
Boston Children's HospitalBristol-Myers SquibbRecruitingGraft Vs Host DiseaseUnited States
-
Fred Hutchinson Cancer CenterFacet BiotechUnknownGraft-vs-Host DiseaseUnited States
-
NYU Langone HealthRecruitingGraft Vs Host DiseaseUnited States
-
Methodist Health SystemEnrolling by invitation
-
Northside Hospital, Inc.Pharmacyclics LLC.Terminated
-
National Cancer Institute (NCI)Completed
-
Alpine Immune Sciences, Inc.TerminatedGraft Vs Host DiseaseUnited States
-
Columbia UniversityIncyte CorporationTerminatedGraft Vs Host Disease | Steroid Refractory GVHDUnited States
-
Massachusetts Eye and Ear InfirmaryOcular Therapeutix, Inc.WithdrawnGraft Vs Host DiseaseUnited States
-
FDA Office of Orphan Products DevelopmentCompleted
-
UNC Lineberger Comprehensive Cancer CenterTerminatedGraft Vs Host DiseaseUnited States
-
Dana-Farber Cancer InstituteCompletedGraft vs Host Disease | Chronic Graft vs Host Disease | cGVHDUnited States
-
Massachusetts General HospitalSeagen Inc.TerminatedGVHD | Graft-vs-Host DiseaseUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Seagen Inc.Completed
-
H. Lee Moffitt Cancer Center and Research InstituteNational Heart, Lung, and Blood Institute (NHLBI); CTI BioPharmaCompletedGVHD | Graft Vs Host DiseaseUnited States
-
Dana-Farber Cancer InstituteRoche-GenentechActive, not recruitingGraft vs. Host DiseaseUnited States
-
Regimmune CorporationCompletedGraft Vs Host Disease | Graft-versus-host-disease | Acute-graft-versus-host Disease | Prevention of aGVHDUnited States
-
EVIVE BiotechnologyMemorial Sloan Kettering Cancer CenterCompletedAcute Graft vs Host DiseaseUnited States
-
MallinckrodtCompletedGraft-versus-Host DiseaseUnited States, Australia, United Kingdom, Slovakia, Brazil, Germany, Italy, Portugal, Turkey
-
SoligenixTerminatedChronic Gastrointestinal Graft vs Host DiseaseUnited States
-
SoligenixTerminatedAcute Gastrointestinal Graft vs Host DiseaseUnited States
-
MallinckrodtCompletedGraft-versus-Host DiseaseUnited States, Australia, France, Italy, Austria, Germany, Portugal, Slovakia, Spain, Switzerland, Turkey, United Kingdom
-
MallinckrodtParexelCompletedChronic Graft Versus Host DiseaseUnited States, France, Germany, United Kingdom, Spain, Italy, Austria, Hungary
-
MallinckrodtPRA Health SciencesTerminatedAcute Graft-versus-Host DiseaseUnited States, Canada, Germany, United Kingdom, Australia, Austria, Belgium, Italy, France, Netherlands, Switzerland
-
Gilead SciencesTerminatedChronic Graft Versus Host DiseaseSpain, Korea, Republic of, United States, Germany, Canada, France, United Kingdom
-
University of Illinois at ChicagoNational Eye Institute (NEI); Genentech, Inc.TerminatedDry Eye | Ocular Graft vs Host DiseaseUnited States
-
Incyte CorporationTerminatedAcute Graft-versus-host DiseaseUnited States, Spain, France, Italy, United Kingdom, Germany
-
Sameem M. Abedin, MDRecruitingGraft-versus-host DiseaseUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedGraft-Versus-Host DiseaseUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteCompletedGraft-Versus-Host-DiseaseUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedGraft-versus-Host DiseaseUnited States
-
M.D. Anderson Cancer CenterAmgenTerminated
-
Ann & Robert H Lurie Children's Hospital of ChicagoUnknownGraft-Versus-Host DiseaseUnited States
-
National Eye Institute (NEI)Completed
-
H. Lee Moffitt Cancer Center and Research InstituteNovartisCompletedGraft-Versus-Host DiseaseUnited States
-
University of Michigan Rogel Cancer CenterCompletedGraft-Versus-Host DiseaseUnited States
-
National Eye Institute (NEI)CompletedGraft-Versus-Host DiseaseUnited States
-
Ladan EspandarWithdrawnGraft-versus-host DiseaseUnited States